Interestingly, loss-of-function mutations in Trem2 increase the risk of late onset AD, and this may be partially due to the inability of Trem2-deficient microglia to transition to stage 2 DAM (Lewcock et al., 2020). Here, TREM2 is linked to Alzheimer disease.